Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 admin Website Related Posts Top 5 Canadian Mining Stocks This Week: Carlton Precious Gains 78 Percent September 6, 2025 Québec Communities Vote “No” to La Loutre Graphite Mine September 6, 2025 Purepoint Uranium Closes Final Tranche of $6 Million Private Placement September 6, 2025